StocksFin Logo
Pacira BioSciences, Inc. country of incorporation
|
|
Mr. David Stack
|
697 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
NuVasive, Inc. country of incorporation
|
|
Mr. J. Christopher Barry
|
2,900 employees
NASDAQ | Healthcare | Medical Devices
Q322 reported Nov 3, 2022 Reporting Period
$167.47M 31.1% vs. Q321 Revenues Q322
69.74% -4.3% vs. Q321 Gross Profit Margin
-0.41% ! -103% vs. Q321 Net Profit Margin
37.47M -37.8% vs. Q321 Free Cash Flow Q322
$-0.02 ! -105% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 9, 2022 Reporting Period
$295.28M 9% vs. Q321 Revenues Q322
72.61% 7.9% vs. Q321 Gross Profit Margin
-0.67% ! 91.6% vs. Q321 Net Profit Margin
15.88M -75.7% vs. Q321 Free Cash Flow Q322
$-0.04 ! 91% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
3.21
0.68
Current Ratio
4.06
1.21
Cash Ratio
0.83
0.34
Price to Book
3.17
2.74
Price to Sales
14.56
7.73
Price to Earnings
-879.42
-288.45